Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation

Nutrition Support Clinical Trial

Official title:
A Randomized, Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-Chamber Parenteral Nutrition Formulation (Oliclinomel N4)

Status Completed

Clinical Trial Summary

The objective of this study is to assess the safety and efficacy of Oliclinomel N4 compared to compounded ternary parenteral nutrition (PN) admixtures for the delivery of PN in hospitalized adults for whom oral or enteral nutrition is not possible, insufficient, or contraindicated.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Nutrition Support

Clinical Trial Details

NCT number	NCT01579097
Study type	Interventional
Source	Baxter Healthcare Corporation
Contact
Status	Completed
Phase	Phase 3
Start date	December 2011
Completion date	January 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05072626` - High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
Recruiting	`NCT06128421` - Individual Nutrition Support in HBV-ACLF Patients at Nutrition Risk	N/A
Recruiting	`NCT04059731` - Postoperative Diet With Hyperproteic Supplement Versus a Supplement With Imunonutrients, in Colorectal Cancer Surgery	N/A
Completed	`NCT01840098` - Leucine and Beta-hydroxy-beta-methylbutyrate (HMB) as Anabolic Nutrients After 36 Hours of Fasting	N/A
Withdrawn	`NCT03727165` - Nocturnal Cyclic Enteral Nutrition Infusion Versus Continuous Infusion of Enteral Nutrition	N/A